T Cell News and Research

Latest T Cell News and Research

An entire trimeric S-protein of SARS-CoV-2 is necessary for protective immune response

Researchers from Seattle Children's Research Institute and the University of Washington described a high-throughput and rapid technique to quantify circulating levels of functional antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), suggesting that the entire viral spike protein should be used to characterize the immune response. Their paper is currently available on the medRxiv* preprint server.

14 Jun 2020

Early respiratory distress syndrome caused by SARS-CoV-2 in a newborn

A recent case report from the researchers at the University of São Paulo, published in the journal CLINICS, shows how newborns can also be infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and develop serious symptoms, even though the most likely route of infection in such cases is still not completely clear.

14 Jun 2020

Cannabis plant may harbor SARS-CoV-2 for at least a week

Researchers at the Medicinal Genomics Corporation have warned that cannabis flowers exposed to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may harbor the virus for at least seven days.

14 Jun 2020

NIAID and Moderna scientists describe SARS-CoV-2 vaccine development

Researchers at the National Institute of Allergy and Infectious Diseases and Moderna Inc., have described the potent neutralizing effects of a candidate vaccine for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that is currently being tested in a phase II trial.

14 Jun 2020

RCSI scientists develop new biomaterial with potential to accelerate bone regeneration

Scientists at RCSI University of Medicine and Health Sciences have developed a new biomaterial that has the potential to accelerate bone regeneration by promoting an immune response that encourages repair and lowers the risk of inflammation.

12 Jun 2020

Study shows how combining two drugs may be an effective treatment for HLH

Scientists at St. Jude Children's Research Hospital, UCSF Benioff Children's Hospitals and Baylor College of Medicine are investigating how to best treat hemophagocytic lymphohistiocytosis (HLH), a rare immune disorder.

12 Jun 2020

Damon Runyon Cancer Research Foundation awards $3.2 million to early-career physician-scientists

The Damon Runyon Cancer Research Foundation has named four new Damon Runyon Clinical Investigators.

12 Jun 2020

Burt's Bees presents new research supporting the power of natural skin care at AAD VMX 2020

Burt's Bees, a leader in science-backed natural skin care, today announced new research supporting the proven power of nature-based solutions that deliver the tolerability and efficacy that are critical for dermatologists and their patients.

12 Jun 2020

Silicone molecules may induce cell death in human cells

Silicone molecules from breast implants can initiate processes in human cells that lead to cell death. Researchers from Radboud University have demonstrated this in a new study that will be published on 12 June in Scientific Reports.

12 Jun 2020

Activating specific brain cells can trigger hibernation-like state in mice

In Sci-Fi movies, astronauts often enter an inactive state in "hibernation chambers" to cross the vastness of space.

12 Jun 2020

Interconnected mycobacteria remain alive for longer

The tuberculosis pathogen Mycobacterium tuberculosis can protect itself better when combined and thus stay alive longer in the air.

12 Jun 2020

Texas Heart Institute and 7 Hills Pharma receive $1.9 million to improve stem cell transplants

The Texas Heart Institute and 7 Hills Pharma received a $1.9 million, Phase II STTR (R42) grant from the National Heart Lung Blood Institute to advance further their lead product 7HP349, a novel integrin activator, to define the optimal dosing schedule for cord blood transplant along with a focus on development and production of a formulation that meets safety standards for filing an IND application with the FDA.

12 Jun 2020

MGH researchers identify key mechanism in X chromosome inactivation

Researchers at Massachusetts General Hospital have identified a key mechanism in X chromosome inactivation, a phenomenon that may hold clues that lead to treatments for certain rare congenital disorders.

12 Jun 2020

CELLINK collaborates with Lonza to advance complete 3D cell culture workflows

CELLINK has collaborated with Lonza to offer a comprehensive 3-dimensional (3D) bioprinting solution designed to advance complete 3D cell culture workflows.

From CELLINK 12 Jun 2020

Assessing the societal and economic benefits of satellites

Resources for the Future (RFF) announced today the winners of three grants, totaling $300,000, to quantify the benefits of using satellite data in decisions that improve socioeconomic outcomes for people and the environment.

12 Jun 2020

New experiment could help attenuate inflammatory reactions during severe Covid-19 cases

The fourth parabolic flight organized by the UZH Space Hub takes off today from Dübendorf airfield. A reorganization taking into account Corona safety measures has made this possible.

12 Jun 2020

Researchers identify link between methylation and the body's circadian rhythms

Every second of every day, countless biochemical reactions take place in our bodies' cells. The organization of this complex system is the result of billions of years of evolution, fine-tuning our functions since the first primordial organisms.

12 Jun 2020

Scientists develop a lead compound to fight chemotherapy-resistant prostate cancer

Scientists of Far Eastern Federal University, together with German and Russian colleagues, have developed a lead compound to fight chemotherapy-resistant prostate cancer.

12 Jun 2020

A protein that helps treat viruses can later interfere with lung tissue repair

Researchers at the Francis Crick Institute have found that a protein which is initially helpful in the body’s immune response to a virus, can later interfere with the repair of lung tissue.

12 Jun 2020

Engineered natural killer cells show promise for treating a form of leukemia

Using induced pluripotent stem cells (iPSCs) and deleting a key gene, researchers at University of California San Diego School of Medicine have created natural killer cells - a type of immune cell - with measurably stronger activity against a form of leukemia, both in vivo and in vitro.

12 Jun 2020

T Cell News and Research

Latest T Cell News and Research

An entire trimeric S-protein of SARS-CoV-2 is necessary for protective immune response

Early respiratory distress syndrome caused by SARS-CoV-2 in a newborn

Cannabis plant may harbor SARS-CoV-2 for at least a week

NIAID and Moderna scientists describe SARS-CoV-2 vaccine development

RCSI scientists develop new biomaterial with potential to accelerate bone regeneration

Study shows how combining two drugs may be an effective treatment for HLH

Damon Runyon Cancer Research Foundation awards $3.2 million to early-career physician-scientists

Burt's Bees presents new research supporting the power of natural skin care at AAD VMX 2020

Silicone molecules may induce cell death in human cells

Activating specific brain cells can trigger hibernation-like state in mice

Interconnected mycobacteria remain alive for longer

Texas Heart Institute and 7 Hills Pharma receive $1.9 million to improve stem cell transplants

MGH researchers identify key mechanism in X chromosome inactivation

CELLINK collaborates with Lonza to advance complete 3D cell culture workflows

Assessing the societal and economic benefits of satellites

New experiment could help attenuate inflammatory reactions during severe Covid-19 cases

Researchers identify link between methylation and the body's circadian rhythms

Scientists develop a lead compound to fight chemotherapy-resistant prostate cancer

A protein that helps treat viruses can later interfere with lung tissue repair

Engineered natural killer cells show promise for treating a form of leukemia

Immunology eBook

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

T Cell News and Research

Latest T Cell News and Research

Immunology eBook

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Newsletters you may be interested in